|Smith & Nephew
Medicine Medical SuppliesWound Dressing
SilverAg Nanoparticle /Nanopowder CAS Number : 7440-22-4
1. ACTICOAT is effective: Dressings in the ACTICOAT range have been proven, in vitro, to be effective against a broad spectrum of over 150 wound pathogens – gram positive, gram-negative, anaerobic and resistant bacteria, including multiple MRSA strains and bacteria containing NDM-1 Carbapenemases. It has a bactericidal effect, unlike some other silvers which are simply bacteriostatic. 2. ACTICOAT is rapid: Dressings in the ACTICOAT range are proven, in vitro, to begin working within 30 minutes. This rapid action gives the bacteria very little time to multiply and allows control to be exerted faster. 3. ACTICOAT is sustained: The ACTICOAT range provides an antimicrobial barrier for the wear time for the dressing; chose between 3 or 7 days to suit your patient. Please refer to the instructions for use for product specific wear time. 4. ACTICOAT is easy to use: the ACTICOAT range of dressings are available in a variety of forms including ACTICOAT Flex; a conformable wound contact layer that is suitable for use under Negative Pressure Wound Therapy ACTICOAT Site specifically designed for percutaneous device sites, ACTICOAT Moisture Control; a foam based dressing and ACTICOAT Absorbent; a calcium alginate dressing. This wide range of dressing types ensures that the appropriate form can be selected.
The ACTICOAT family consists of dressings which are flexible, absorbent and conformable and that provide an efficient and effective barrier to bacterial penetration. ACTICOAT has been shown to offer significant clinical and economic results compared to other silver dressings.The silver on ACTICOAT dressings is the unique nanocrystalline SILCRYST silver. Silcryst silver is created via a physical vapour deposition process to form a nanocrystalline structure with a large accessible surface area.